Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
- 19 February 2005
- journal article
- Published by Elsevier BV in Virology
- Vol. 334 (1), 74-82
- https://doi.org/10.1016/j.virol.2005.01.034
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entryBiochemical and Biophysical Research Communications, 2004
- Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in FerretsJournal of Virology, 2004
- Cellular entry of the SARS coronavirusTrends in Microbiology, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoVPhysiological Genomics, 2004
- One Year After Outbreak, SARS Virus Yields Some SecretsScience, 2004
- Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with ReceptorJournal of Virology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003